Pakistan Infection Control Market - Strategic Insights and Forecasts (2026-2031)

The Pakistan Infection Control market is forecast to grow at a CAGR of 5.0%, reaching USD 47.0 million in 2031 from USD 35.6 million in 2026.

The PPE & Consumables segment is the fastest growing due to continuous demand for masks, gloves, and protective gear driven by infection prevention awareness and outbreaks such as Dengue.

• In 2025, consumables were the major segment by type, accounting for X% share by value, followed by equipment segment, contributing to X% share in the same year.

• By Type, the Consumables segment led growth owing to their recurring usage and essential role in maintaining hygiene standards across healthcare facilities.

• The healthcare sector is the highest growing segment due to increasing hospital admissions, expanding infrastructure, and a strong focus on infection control supported by the Ministry of National Health Services Regulations and Coordination.

Market Dynamics

Drivers

Rising Incidence of Healthcare-Associated Infections (HAIs)

The increasing number of healthcare-associated infections (HAIs) and high burden of infectious diseases (like Dengue) are the major factors driving the infection control market in Pakistan. Hospitals and diagnostic centers experiencing the pressure of frequent outbreaks of dengue and other communicable diseases, which increase the risk of hospital transmission and cross-contamination. As a result, there is a rising demand for proper infection prevention measures like sterilization, surface disinfection, vector control and use of PPE.

• As of mid 2025, the province of Sindh has registered a total of 295 dengue cases, out of which 260 cases, almost 90%, were from Karachi, establishing the city as the epicenter of the region.

• During June 2025, however, 32 new dengue cases were confirmed in Karachi, whereas two other divisions, namely Hyderabad and Shaheed Benazirabad, reported no new cases for the month.

• This surge in patient volume also raised the risk of cross-contamination. That made the infection prevention measures essential not only to the safety of the patients but also for protecting the healthcare workers.

• Thus, hospitals and clinics had to put in place more stringent sterilization procedures, frequent surface cleaning, correct disposal of biomedical waste, and greater use of personal protective equipment (PPE).

• As a result, the continuous threat of dengue and similar infections is driving nationwide sustained demand for advanced infection control solutions.

Market Segmentation

By Type: Equipment

Pakistan’s infection control market is expanding steadily across equipment, consumables, and services, supported by stronger infection prevention regulations, rising patient volumes, and increased public healthcare investments.

In terms of frequency of purchase, consumables are expected to make up the vast majority of the market (e.g., PPE consumables, disinfectant cleaning products, and laboratory test kit consumables) because they are consumed or used daily by healthcare workers and facilities.

Equipment is witnessing growth with hospital modernisation and improved sterilisation infrastructure, while services are gradually expanding through training programs, monitoring systems, and outsourced infection control solutions driven by compliance requirements. In Pakistan, infection control equipment plays an essential role in providing a successful healthcare system. The framework for infection control equipment is based upon guidance from the national framework developed by the National Institute of Health and supported by the Ministry of National Health Services.

• To ensure that medical instruments are used in an aseptic manner, hospitals are required to have the appropriate sterilisation equipment, including autoclaves, chemical disinfectants and high-level disinfection systems.

• Additionally, hospitals are increasingly using environmental infection control equipment that is monitored by regulatory bodies, like provincial health commissions. This equipment includes hand hygiene stations, alcohol-based hand rub dispensers, and cleaning surface systems.

• The market for infection control equipment in Pakistan is changing due to the greater regulatory enforcement, increased procurement of PPE and sanitation equipment, and an overall alignment with WHO-supported IPC (Infection Prevention and Control) standards as a result of infectious disease outbreaks.

• Pakistan’s population is projected to increase from 247,504,495 in 2023 to 371,863,793 by 2050, indicating steady demographic expansion. This growth supports the infection control equipment segment by driving demand for hospitals, diagnostic centres, and healthcare infrastructure.

• Higher patient volumes increase the need for sterilisation, disinfection, and protective equipment. Additionally, urbanisation and government healthcare investments are accelerating the adoption of advanced infection control technologies to manage disease spread and maintain public health standards.

By End-User: Healthcare

The expansion of the infection control market within Pakistan has occurred as a result of an increasing need for stricter rules and regulations within many sectors, such as Healthcare, Food and Beverage, Pharmaceuticals/Biotechnology, and chemicals, as a result of the rise in the risk of infection and/or the need for better hygiene and more safety measures.

Within the healthcare sector, there is a trend of continued high patient volume, with many instances of hospital-acquired infections; the healthcare sector is continuously in need of infection control methods. The fastest-growing sector will continue to be Pharmaceuticals/Biotechnology due to the stringent regulations on sterilisation and compliance with both International Quality/Stability and Contamination Control Standards.

In Pakistan, infection control equipment plays an essential role in providing a successful healthcare system. The framework for infection control equipment is based upon guidance from the national framework developed by the National Institute of Health and supported by the Ministry of National Health Services. While the IPC (Infection Prevention and Control) guidelines are supported by the government, they emphasise the need for all facilities, regardless of level, to use essential infection control equipment in order to reduce HAIs (Healthcare-associated Infections) and AMR (Antimicrobial Resistance).

• According to government guidelines, all of the healthcare entities must implement strict infection prevention measures to minimise the risk of healthcare-associated infections and protect their patients and the healthcare providers who care for them.

• The healthcare sector dominates the infection control end-user segment of the Pakistan infection control market due to the high volume of patients being treated.

• The growth in 3M’s net sales from $24.6 billion in 2024 to $24.9 billion in 2025 reflects strengthening global demand for infection control products such as PPE, sterilisation solutions, and healthcare safety equipment. This is relevant to the Pakistan infection control market as multinational suppliers like 3M play an important role in providing advanced infection prevention technologies to hospitals and healthcare systems.

• The infection control industry in Pakistan's healthcare sector is in the midst of growth due to the increasing population and expanding healthcare demands.

• The total population in Pakistan is projected to reach 255.2 million by 2025, putting added pressure on health care facilities and infrastructure. This leads to a higher number of patients being treated, resulting in an increase in the incidence of hospital-acquired infections and the corresponding demand for infection control products (including medical equipment and consumables), and related services.

List of Companies

• Intra Health (Pvt.) Ltd.

• 3M Company

• AGP Limited

• Reckitt Benckiser (Pakistan) Ltd

• Medinostic Healthcare (Pvt) Ltd.

• Getz Pharma (Private) Limited

• Barrett Hodgson Pakistan

• Nipro Medical Pakistan

• Sami Pharmaceuticals (Pvt.) Ltd.

• Martin Dow Limited

3M is a globally recognized multinational technology company headquartered in the United States, known for its diversified portfolio spanning healthcare, safety, industrial, and consumer markets. Founded in 1902, the company operates in more than 70 countries and develops science-based solutions across multiple sectors. In healthcare, 3M has built a strong reputation through advanced medical technologies, infection prevention systems, sterilization monitoring products, and disinfection solutions that support hospitals, laboratories, and industrial users worldwide.

In the infection control market, 3M is a major player offering a comprehensive range of products, including sterilization assurance systems, disinfectants, enzyme cleaners, hand hygiene products, personal protective equipment, and contamination prevention solutions. Its infection control portfolio is widely used in hospitals and clinical settings to reduce healthcare-associated infections through sterilization monitoring, cross-contamination prevention, and surface disinfection protocols. The company’s solutions are especially valued for integrating sterilization validation with infection prevention workflows, making 3M a key contributor to modern infection control practices globally.

Pakistan Infection Control Market Scope: